Valeant Pharmaceuticals International Inc (NYSE:VRX)

21.94
BATS BZX Real-Time Price
As of 11:55am ET
 -0.09 / -0.41%
Today’s Change
10.94
Today|||52-Week Range
24.43
+5.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line912.2M-287.8M-2.4B2.4B
 
 
 
 
 
Depreciation1.7B2.4B2.9B2.9B
 
 
 
 
 
Total Other Cash Flow319.1M849.0M1.9B460.0M
 
 
 
 
 
Funds From Operations3.0B2.9B2.1B1.3B
 
 
 
 
 
Funds From/For Other Operating Expenses668.4M822.2M110.0M-844.0M
 
 
 
 
 
Net Cash Flow - Operating Activities2.3B2.1B2.0B2.2B
 
 
 
 
 
 
InvestingIncrease In Investments-147.9M-49.3M-1.0M-7.0M
 
 
 
 
 
Decrease In Investments129.1M66.7M17.0M2.0M
 
 
 
 
 
Capital Expenditures-291.6M-235.2M-235.0M-171.0M
 
 
 
 
 
Fixed Asset Disposal1.5B12.8M199.0M3.3B
 
 
 
 
 
Net Assets From Acquisitions -1.1B-15.5B-19.0M0.00
 
 
 
 
Other Investing - Uses0.00-26.3M-30.0M-25.0M
 
 
 
 
Other Investing - Sources0.00184.6M0.000.00
 
 
Net Cash Flow Investing-99.7M-15.6B-125.0M2.9B
 
 
 
 
 
 
FinancingShort Term Borrowings-9.0M-300.0K3.0M-7.0M
 
 
 
 
 
Long Term Borrowings1.6B17.8B1.2B9.4B
 
 
 
 
 
Long Term Debt Reduction-3.9B-5.2B-2.4B-14.2B
 
 
 
 
 
Net Proceeds Stock Sale17.2M1.5B33.0M0.00
 
 
 
 
Common Preferred Redeemed0.00-72.4M0.000.00
 
 
Common Dividends0.00----0.00--
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing17.1M56.8M----
 
 
 
Other Uses - Financing158.4M301.9M683.0M67.0M
 
 
 
 
 
Net Cash Flow - Financing-2.4B13.8B-1.9B-4.9B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-29.0M-30.1M-54.0M41.0M
 
 
 
 
 
 
Net Change In Cash-248.7M310.0M-1.0M214.0M